Tatsuaki Morokata, Ph.D.

President, Head of Scouting, Astellas Innovation Management LLC
Drug Discovery Research
Astellas Pharma Inc.

 


Dr. Tatsuaki Morokata joined Astellas in 1995 (formerly Yamanouchi Pharmaceutical Co. Ltd.), and he currently manages Astellas Innovation Management LLC which are responsible for acquiring internal and external innovation opportunities in the preclinical development stage, including strategy planning, screening, scientific, assessment and alliance negotiations.

His other professional and managerial experience at Astellas include the following: Divisional Senior Vice President, Innovation & Incubation Research Labs and President, Astellas Innovation Management LLC (2018- March 2019); Executive Director, New Product Science Strategy Group, Product and Portfolio Strategy (2017-2018); Executive Director, ImmunoScience Research Unit, Research and Portfolio Science (2014-2016); Senior Director, Innovation Research Lab, Molecular Medicine Research Labs (2012-2013). Post Doctorial Research Fellow at Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School (2009 to 2010).

Dr. Morokata has more than 25 years of experience in immunology research from early to late stage drug discovery.
He received his Ph.D. in Pharmaceutical Science from the University of Tokyo.   

 

Kazunori Inabe, Ph.D., M.B.A.

Executive Director, Head of Partnering Process MAnagement, AIM San Francisco

 

 


Dr. Inabe is the Head of Early-stage Partnering, AIM San Francisco since April 2019. He most recently served as Senior Director at Innovation Management, Drug Discovery Research, Astellas Pharma in Japan. There, he led a Japan-based team responsible for transaction and alliance management of projects in early-stage partnerships with biotech companies or academic institutions. In this role, he was involved in partnerships with nearly 20 biotech companies or academic institutions, such as Mitobridge, Inc., Proteostasis Therapeutics, and Harvard Medical School. He also served as a member of the Joint Steering Committee or Alliance Manager for the partnerships with Cytokinetics, Inc., Mitobridge, Inc. and Potenza Therapeutics, Inc.  

From 2009 to 2011, Dr. Inabe was a member of Astellas Venture Management LLC, a US-based corporate venture capital arm of Astellas Pharma, that is engaged in strategic investment activities in the biotech industry. Prior to joining Yamanouchi, the former company of Astellas, in 2002, Dr. Inabe’s career in life sciences included work as an Assistant Professor at Kansai Medical University, Osaka, Japan. He holds a Ph.D. in Medical Science from Hokkaido University and an M. B. A. from Globis University. 

 

Takeshi Kurama, Ph.D.

Director
AIM Cambridge

 

Tomoya Oe, Ph.D.

Associate Director
AIM Cambridge

 

Tomohiro Yoshida

Associate Director
AIM Cambridge

 

 
Aya Hoshino, Ph.D.

Senior Manager
AIM Cambridge

 

Akira Okajima

Senior Manager
AIM Cambridge

 

Shinichi Miyake, Ph.D.

Associate Director
AIM San Francisco

 

 
Shingo Yamasaki, Ph.D.

Associate Director
AIM San Francisco

 

Munemichi Ohe, Ph.D.

Senior Manager
AIM San Francisco